Cargando…

Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and Its Potential for Therapy as a Target

Asthma is a chronic inflammatory disease that undermines the airways. It is caused by dysfunction of various types of cells, as well as cellular components, and is characterized by recruitment of inflammatory cells, bronchial hyperreactivity, mucus production, and airway remodelling and narrowing. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Han, Ying, Songmin, Dai, Yuanrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735647/ https://www.ncbi.nlm.nih.gov/pubmed/29359169 http://dx.doi.org/10.1155/2017/3743048

Ejemplares similares

Roxithromycin attenuates inflammation via modulation of RAGE-influenced calprotectin expression in a neutrophilic asthma model
por: Gu, Xiaofei, et al.
Publicado: (2021)

Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway
por: Xu, Tingting, et al.
Publicado: (2019)

hMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation
por: Cruz, Fernanda F., et al.
Publicado: (2018)

Deletion of Shp2 in bronchial epithelial cells impairs IL-25 production in vitro, but has minor influence on asthmatic inflammation in vivo
por: Qiu, Zhangwei, et al.
Publicado: (2017)

Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma
por: Green, Benjamin J., et al.
Publicado: (2014)

Relationship between Th17-mediated immunity and airway inflammation in childhood neutrophilic asthma
por: Wei, Qing, et al.
Publicado: (2021)

Periostin: its role in asthma and its potential as a diagnostic or therapeutic target
por: Li, Wei, et al.
Publicado: (2015)

Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology
por: Muefong, Caleb N., et al.
Publicado: (2020)

Galectin-3: its role in asthma and potential as an anti-inflammatory target
por: Gao, Peng, et al.
Publicado: (2013)

Induction of neutrophil apoptosis by a Bcl-2 inhibitor reduces particulate matter-induced lung inflammation
por: Geng, Xinwei, et al.
Publicado: (2018)

Targeting Neutrophilic Inflammation Using Polymersome-Mediated Cellular Delivery
por: Robertson, James D., et al.
Publicado: (2017)

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma
por: Pelaia, Girolamo, et al.
Publicado: (2015)

Sputum colour can identify patients with neutrophilic inflammation in asthma
por: Pabreja, Kavita, et al.
Publicado: (2017)

Coexistence of diffuse panbronchiolitis and asthma: reciprocity of neutrophilic and eosinophilic inflammation
por: Takeyama, Kiyoshi, et al.
Publicado: (2017)

On Asthma: Its Pathology and Treatment
Publicado: (1869)

On Asthma: Its Pathology and Treatment
Publicado: (1864)

Piperlongumine reduces ovalbumin-induced asthma and airway inflammation by regulating nuclear factor-κB activation
por: Lu, Chun, et al.
Publicado: (2019)

Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma
por: Varricchi, Gilda, et al.
Publicado: (2021)

Neutrophils and Asthma
por: Yamasaki, Akira, et al.
Publicado: (2022)

Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma
por: Bullone, Michela, et al.
Publicado: (2017)

Neuropilin‐2 regulates airway inflammation in a neutrophilic asthma model
por: Immormino, Robert M., et al.
Publicado: (2021)

Potential Masking of Airway Eosinophilic Inflammation by Combination Therapy in Asthma
por: Lee, Byung-Jae, et al.
Publicado: (2014)

Drug discovery for neutrophil-mediated inflammation
Publicado: (2014)

Schizophyllum commune induces IL-17-mediated neutrophilic airway inflammation in OVA-induced asthma model mice
por: Hanashiro, Jun, et al.
Publicado: (2019)

On Bronchial Asthma: Its Pathology and Treatment
Publicado: (1912)

On Bronchial Asthma: Its Pathology and Treatment
Publicado: (1890)

Asthma—Its Pathology, Treatment, &c.
por: Powers, N. F.
Publicado: (1857)

Neutrophil-Initiated Myocardial Inflammation and Its Modulation by B-Type Natriuretic Peptide: A Potential Therapeutic Target
por: Liu, Saifei, et al.
Publicado: (2018)

Neutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications
por: Uribe-Querol, Eileen, et al.
Publicado: (2022)

Targeting Neutrophils for Promoting the Resolution of Inflammation
por: Filep, János G.
Publicado: (2022)

TIPE2 May Target the Nrf2/HO-1 Pathway to Inhibit M1 Macrophage–Related Neutrophilic Inflammation in Asthma
por: Shi, Bingqing, et al.
Publicado: (2022)

Association of autophagy related gene polymorphisms with neutrophilic airway inflammation in adult asthma
por: Pham, Duy Le, et al.
Publicado: (2016)

Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma
por: Enweasor, Chioma, et al.
Publicado: (2021)

Work‐related dysphonia in subjects with occupational asthma is associated with neutrophilic airway inflammation
por: Migueres, Nicolas, et al.
Publicado: (2023)

Targeting Prolyl Endopeptidase with Valproic Acid as a Potential Modulator of Neutrophilic Inflammation
por: Abdul Roda, Mojtaba, et al.
Publicado: (2014)

Role and Therapeutic Targeting Strategies of Neutrophil Extracellular Traps in Inflammation
por: Li, Xiang, et al.
Publicado: (2023)

Regulation of neutrophil trafficking by the lipid mediators of inflammation
por: Marleau, S, et al.
Publicado: (2004)

Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases
por: Marzano, Angelo V., et al.
Publicado: (2019)

Necrostatin-1 Ameliorates Neutrophilic Inflammation in Asthma by Suppressing MLKL Phosphorylation to Inhibiting NETs Release
por: Han, X. A., et al.
Publicado: (2020)

Bronchial Asthma: Its Causes, Pathology, and Treatment
Publicado: (1887)

Cannot write session to /tmp/vufind_sessions/sess_o6h102t421nu7bqr7hjn2en3eo